| Up
2006P-0147:
Determine whether Risperdal M Tab (Risperidone) Orally Disintegrating
Tablets, 3 mg and 4 mg (NDA No. 21-444), was Voluntarily Withdrawn
or Withheld from Sale for Safety or Efficacy Reasons
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
|
| CP1
|
| 03/31/2006
|
| 03/31/2006
|
| Private Industry
|
| Lachman Consultant
Services, Inc.
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| Robert W. Pollock
|
|
|
|
|
| ACK1
|
| 03/31/2006
|
| 03/31/2006
|
| Federal Government
|
| HFA-305 to Lachman
Consultant Services, Inc.
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
|
| Signature:
|
| Jennie C. Butler
|
|
|
|
|
| C1
|
| 05/11/2006
|
| 05/10/2006
|
| Individual Consumer
|
| D. Lowe
|
|
|
|
|
|
|
| pdf
Attachment
|
|
|
|
|
|
|
| WDL1
|
| 06/29/2006
|
| 06/28/2006
|
| Private Industry
|
| Lachman Consultant
Services, Inc.
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| Robert W. Pollock
| |
Top | Up
Page last updated
July 27, 2006
kk
Dockets Home Page | Dockets
Contacts and Location | Operating
Status | Item
Code Definitions | Federal
Register
FDA Home Page | Search
FDA Site | FDA A-Z Index
| Contact FDA
FDA/Dockets Management |
